Christine A. Carberry

63 year

Health Technology

Consumer Services

Profile

Christine A.
Carberry worked as Vice President-Program & Alliance Management at Biogen, Inc. She then worked as Chief Operating Officer & Senior Vice President at Keryx Biopharmaceuticals, Inc. from 2017 to 2018.
Prior to that, she was VP-Technical Operations & Alliance Management at FORUM Pharmaceuticals, Inc. from 2014 to 2016.
Carberry holds a graduate degree from Boston University and an undergraduate degree from the University of New Hampshire.

Former positions of Christine A. Carberry

Companies	Position	End
KERYX BIOPHARMACEUTICALS	Chief Operating Officer	2018-12-11
FORUM Pharmaceuticals, Inc. FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA.	Corporate Officer/Principal	2016-04-30
BIOGEN INC.	Corporate Officer/Principal	-

See the detail of Christine A. Carberry's experience

Training of Christine A. Carberry

Boston University	Graduate Degree
University of New Hampshire	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christine A. Carberry's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BIOGEN INC.	Health Technology

Private companies	2
FORUM Pharmaceuticals, Inc. FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA.	Health Technology
Keryx Biopharmaceuticals, Inc. Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA.	Health Technology